Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
1 branded products available
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF code shown is the factual mapping value distributed by NHS Business Services Authority (NHSBSA) in the dm+d supplementary file under OGL v3.0; it is not affiliated with, nor licensed from, the publishers of the British National Formulary.
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing the 50 most relevant studies.
Reviews & meta-analyses: 1 · Randomised trials: 1 · 1903–2025
Showing the 50 most relevant studies, sorted by most relevant.
L Long, E Ernst
British Homeopathic Journal, 2001
Roberto de Queiroz Padilha, R. Riera, Á. Atallah
Homeopathy, 2011
S. Mohammad, A. Pinto, Rodrigo Augusto da Silva, et al.
Homeopathy, 2023
José Ângelo Sebastião Araujo Anjos, Luis Enrique Sánchez
Geologia Ambiental e Médica do Estado da Bahia, 2023
The purpose of this investigation was to evaluate the efficiency of a wetland that occurs on the premises of a lead industrial plant located in Santo Amaro da Purificação, Bahia, as a measure to control contamination from a slag dam contaminated with heavy metals. Initially, an annual survey was proposed with weekly sampling of rainwater and surface water from the wetland, in order to assess the efficiency of the wetland, by surveying the concentrations of metals from the leaching and/or slag solubilization processes in their entry and exit points from the flooded system and concentrations and potential availability of the metals retained in the sediments of the floodplain. The following parameters were selected: for rainwater, pH and volume; for surface water, the concentrations of the metals Lead (Pb), Cadmium (Cd), Zinc (Zn), Copper (Cu), Aluminum (Al), Manganese (Mn), Iron (Fe), Magnesium (Mg) and Calcium ( Ca) and support parameters pH, Eh, conductivity, Dissolved Oxygen (OD) and temperature. For the soil and sediment of the wetland, the concentrations of metals like Pb, Cd, Zn and Cu e, determination by analyses of the sequential extraction of the total removed by the system in its different phases and the potential availability of heavy metals. However, a modification of the investigation strategy had to be made due to a court decision that determined the covering of the slag and closing of the access to the wetland. The work was then divided into three phases, considering the surveys carried out before, during and after the coating. The data collected in the five months before the coating showed that the metals cadmium, lead, copper and zinc have been retained by the wetland and that this system was 100% efficient for the copper and zinc metals, 82% for the lead and 73 % for cadmium. The support parameters that influence the removal of these metals were the pH, between neutral to alkaline, and Eh, in the surface water oxidation range, besides the high cation exchange capacity of the montmorillonite present in the sediment. As for the potential availability of metals, cadmium, lead and zinc present high values, while copper is preferentially concentrated in the residual phase. The second stage of the survey carried out during the slag coating showed that there was little migration of metals from the wetland area, although the company did not comply with the technical standards for slag coating. In the third stage, a survey was carried out at the exit of the wetland and the drainage near the Subaé River. The analyses showed the great availability of cadmium in the flooded system, a mechanism triggered by the erosion of the contaminated soil disposed on the slag and the great solubility of cadmium. It can thus be concluded that the wetlands are efficient in retaining metals. The reduction of its area is undesirable, as it tends to decrease its efficiency, as a surface water pollution control system. It is recommended to build a new wetland downstream of the existing one.
Abstract licence: CC BY-NC-ND
Vademecum Anthroposophische Arzneimittel, 2024
Anindya Ganguly
JOURNAL OF ADVANCED RESEARCH IN AYURVEDA, YOGA, UNANI, SIDHHA & HOMEOPATHY, 2025
Vademecum Anthroposophische Arzneimittel, 2024
Vademecum Anthroposophische Arzneimittel, 2024
Vademecum Anthroposophische Arzneimittel, 2024
Vademecum Anthroposophische Arzneimittel, 2024
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.